Bio-Works Confirms a New Order for WorkBeads affimAb for Use in Antibody Production for 11.2 MSEK

Today, Bio-Works confirmed a new orders for WorkBeads affimAb – a product used in the purification of therapeutic antibodies for use in pharmaceutical production. The total order value amounts to 11.2 million SEK. The orders will be delivered as three separate shipments during the Q1-Q3, 2025.

"These orders confirm that our focus on building partnerships with our process customers is paying off," says Lone Carlbom, CEO of Bio-Works.
"This customer has now integrated WorkBeads affimAb into several processes, which reinforces that our products are of high quality and that Bio-Works brings value to our customers."

WorkBeads affimAb is a modern affinity resin well-suited for large-scale purification of monoclonal antibodies, and these orders are the result of a letter of intent that Bio-Works communicated earlier this quarter.

This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 14-01-2025 13:33 CET.

Contacts
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Lone Carlbom, CEO, e-mail: lone.carlbom@bio-works.com, phone: +46(0)8-502 705 84.

About Bio-Works

Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.

Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.